Cost-Effectiveness of Dapagliflozin Versus Dpp-4 Inhibitors as Monotherapy in the Treatment of Type 2 Diabetes Mellitus From A Uk Health Care Perspective.
Value Health
; 17(7): A347, 2014 Nov.
Article
in En
| MEDLINE
| ID: mdl-27200659
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Evaluation_studies
/
Health_economic_evaluation
Language:
En
Journal:
Value Health
Journal subject:
FARMACOLOGIA
Year:
2014
Document type:
Article
Affiliation country:
Países Bajos